Teprotumumab has been shown to be effective in reducing inflammation and proptosis in patients with thyroid eye disease. This study focused on the short and long-term effects of teprotumumab on diplopia and strabismus. Twenty patients were followed after recei... ...

请注册登录后继续浏览